Microba Life Sciences Limited (ASX:MAP)

Australia · Delayed Price · Currency is AUD

0.0870

+0.0010 (1.16%)

Feb 4, 2026, 11:57 AM AEST

Revenue by Product

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Year Ending	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
Testing Services & Supplements	12.09M
Testing Services & Supplements Growth	123.06%

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Year Ending	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
United Kingdom	4.53M
United Kingdom Growth	366514.48%
Australia	4.20M
Australia Growth	32.98%
Europe	1.77M
Europe Growth	63.67%
United Arab Emirates	662.34K
United Arab Emirates Growth	45.03%
United States	602.86K
United States Growth	8.73%
Ireland	168.85K
New Zealand	127.03K
New Zealand Growth	-22.34%
Asia	22.05K